Fig. 1From: Management of people with epilepsy during the COVID-19 pandemic: a national survey among epileptologists in ChinaSummary of the most-frequently suggested impacting factors on epilepsy care during the COVID-19 pandemic. ASMs, antiseizure medicationsBack to article page